Literature DB >> 1906549

The antigen of hepatitis delta virus: examination of in vitro RNA-binding specificity.

M Chao1, S Y Hsieh, J Taylor.   

Abstract

The only known protein of hepatitis delta virus (HDV), the delta antigen, is found both within virus particles and within the nucleus of the infected cell, where it has one or more roles essential for RNA genome replication. Others have demonstrated that the antigen has the ability, in vitro, to specifically bind HDV RNA species. We report a further examination of this phenomenon, using partially purified recombinant protein, expressed as a fusion with the staphylococcal protein A. From Northwestern (RNA-immunoblot) analyses with both complete and various subdomains of HDV genomic and antigenomic RNAs, we found that a necessary feature for specific binding was that the RNA be able to fold to some extent into the so-called rodlike structure; this structure is a predicted intramolecular partial base-pairing of the circular RNA, with about 70% of all bases involved, so as to produce an unbranched rodlike structure. Six different subregions of the HDV rodlike structure, three on the genomic RNA and three on its complement, the antigenomic RNA, were tested and found to be sufficient for antigen binding. However, features in addition to the rodlike structure may also be necessary for specific binding, because we found that a similar structure present in the RNA of the potato spindle tuber viroid did not allow binding.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906549      PMCID: PMC248837     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Stable expression of hepatitis delta virus antigen in a eukaryotic cell line.

Authors:  T B Macnaughton; E J Gowans; B Reinboth; A R Jilbert; C J Burrell
Journal:  J Gen Virol       Date:  1990-06       Impact factor: 3.891

2.  Structure and replication of the genome of the hepatitis delta virus.

Authors:  P J Chen; G Kalpana; J Goldberg; W Mason; B Werner; J Gerin; J Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

Review 3.  Hepatitis delta virus: cis and trans functions required for replication.

Authors:  J M Taylor
Journal:  Cell       Date:  1990-05-04       Impact factor: 41.582

4.  A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta.

Authors:  A J Weiner; Q L Choo; K S Wang; S Govindarajan; A G Redeker; J L Gerin; M Houghton
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

5.  Electrophoretic separation of complexes involved in the splicing of precursors to mRNAs.

Authors:  M M Konarska; P A Sharp
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication.

Authors:  M Chao; S Y Hsieh; J Taylor
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

8.  Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA.

Authors:  J H Lin; M F Chang; S C Baker; S Govindarajan; M M Lai
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

9.  Hepatitis delta virus genome replication: a polyadenylated mRNA for delta antigen.

Authors:  S Y Hsieh; M Chao; L Coates; J Taylor
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

10.  Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope.

Authors:  F Bonino; K H Heermann; M Rizzetto; W H Gerlich
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

View more
  42 in total

1.  Interactions between hepatitis delta virus proteins.

Authors:  G Moraleda; K Dingle; P Biswas; J Chang; H Zuccola; J Hogle; J Taylor
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Nucleic acid binding properties of the nucleic acid chaperone domain of hepatitis delta antigen.

Authors:  Chun-Chung Wang; Tsung-Cheng Chang; Ching-Wen Lin; Hsiu-Ling Tsui; Page B C Chu; Bo-Shun Chen; Zhi-Shun Huang; Huey-Nan Wu
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

3.  Oligomerization of hepatitis delta antigen is required for both the trans-activating and trans-dominant inhibitory activities of the delta antigen.

Authors:  Y P Xia; M M Lai
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

4.  Structural requirements for RNA editing in hepatitis delta virus: evidence for a uridine-to-cytidine editing mechanism.

Authors:  J L Casey; K F Bergmann; T L Brown; J L Gerin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

5.  Reconstitution in cultured cells of replicating HDV RNA from pairs of less than full-length RNAs.

Authors:  Severin O Gudima; Jinhong Chang; John M Taylor
Journal:  RNA       Date:  2004-12-01       Impact factor: 4.942

6.  Regulation of polyadenylation of hepatitis delta virus antigenomic RNA.

Authors:  S Y Hsieh; J Taylor
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

7.  Prominent polypurine and polypyrimidine tracts in plant viroids and in RNA of the human hepatitis delta agent.

Authors:  A D Branch; S E Lee; O D Neel; H D Robertson
Journal:  Nucleic Acids Res       Date:  1993-07-25       Impact factor: 16.971

8.  Local helix content and RNA-binding activity of the N-terminal leucine-repeat region of hepatitis delta antigen.

Authors:  J W Cheng; I J Lin; Y C Lou; M T Pai; H N Wu
Journal:  J Biomol NMR       Date:  1998-07       Impact factor: 2.835

9.  Ribonucleoprotein complexes of hepatitis delta virus.

Authors:  W S Ryu; H J Netter; M Bayer; J Taylor
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Assembly of hepatitis delta virus particles.

Authors:  W S Ryu; M Bayer; J Taylor
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.